Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolization

BACKGROUND: Stereotactic ablative radiotherapy (SABR) can deliver tumoricidal doses and achieve long-term control in early hepatocellular carcinoma (HCC). However, limited studies have investigated the safety and effectiveness of SABR in patients with advanced diseases that is unsuitable for transar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Med Oncol
Autors principals: Lee, Hsin-Lun, Tsai, Jo-Ting, Chen, Chun-You, Lin, Ying-Chun, Ho, Chin-Beng, Ting, Lai-Lei, Kuo, Chia-Chun, Lai, I-Chun, Lin, Chun-Yu, Tang, Jui-Hsiang, Huang, Yu-Min, Kao, Wei-Yu, Cheng, Sheng-Wei, Shen, Chia-Ning, Chen, Shang-Wen, Chiou, Jeng-Fong
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2019
Matèries:
Early Diagnosis and Therapeutic Advances for Liver Cancer: From Bench to Bedside
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6893933/
https://ncbi.nlm.nih.gov/pubmed/31839809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919889002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars